Aquestive Therapeutics CEO Daniel Barber reports sale of $105,600 in common shares
AQST•Aquestive Therapeutics President and CEO Daniel Barber sold 25,000 common shares on Oct. 15, 2026, for $4.224 per share, leaving him with 627,317 shares.
1. Share sale
Daniel Barber, Aquestive Therapeutics’ president, CEO and a director, sold 25,000 shares of common stock on Oct. 15, 2026, at a reported price of $4.224 per share. He directly owned 627,317 shares after the transaction.
